EUVIMEDEUVIMED entdecken
Crossref

AARC score and urine NGAL predict terlipressin non-response and mortality in patients with acute-on-chronic liver failure

Rakhi Maiwall, Samba Siva Rao Pasupuleti, Archana Rastogi, Fagun Sharma, Ashini Kumar Hidam, Sherin Thomas, Shiv Kumar Sarin

Hepatology International · 2025

DOI: 10.1007/s12072-024-10749-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hepatology International, 2025. Verfasst von Rakhi Maiwall und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology, Institute of Liver and Biliary Sciences, D1 Vasant Kunj, New Delhi, 110070, India. rakhi_2011@yahoo.co.in. Hauptthemen laut MEDLINE: Terlipressin, Lipocalin-2, Acute-On-Chronic Liver Failure, Hepatorenal Syndrome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: DST-SERB, ICMR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIM: Acute-on-chronic liver failure (ACLF) patients with hepatorenal syndrome (HRS-AKI) have limited response to vasoconstrictors and worse outcomes, requiring biomarkers for early detection. METHODS: In a prospective cohort of ACLF patients (n = 240), urine NGAL was performed in patients with the clinical diagnosis of HRS-AKI, while in a subset of patients (n = 30), a complete panel of 17 urinary biomarkers was assessed for identifying terlipressin non-response (T-NR). RESULTS: ACLF patients with HRS-AKI, aged 45.84 ± 10.6 years, 91.2% males, 74.2% with alcohol etiology, mean urine NGAL of 1541.66 ± 1684.69 ng/ml, AARC score 10.19 ± 1.86, 155 (64.5%) had T-NR at day 4. T-NR was maximal for AARC grade 3 and was associated with a higher need of dialysis (50.3% vs 5.9%; OR 16.21, 6.23-42.19) and 28-day mortality (49.0% vs. 17.9%; HR 3.42, 1.96-5.95). AARC grade 3 (OR 38.21, 2.93-497.74), (HR 5.10, 1.19-21.84) and urine NGAL (OR 11.53, 5.66-23.49; AUROC 0.97, NGAL > 900 ng/ml) (HR 1.23, 1.02-1.49) were independent predictors of T-NR and 28-day mortality, respectively. It was interesting to observe a significant elevation in renal injury and a decrease in the repair markers in T-NR (p < 0.05). CONCLUSION: Almost 60% of patients with ACLF and HRS-AKI experience non-response to terlipressin which predicts higher mortality and need for dialysis. High NGAL above 900 ng/ml predicts T-NR with 100% specificity for T-NR. ACLF patients with HRS, with AARC grade 3 and high NGAL have a high likelihood of T-NR and should be considered for alternative therapeutic modalities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TerlipressinLipocalin-2Acute-On-Chronic Liver FailureHepatorenal SyndromeVasoconstrictor AgentsHumansMaleFemaleMiddle AgedBiomarkersProspective StudiesAdultPredictive Value of TestsPrognosis

Stichwörter der Autor:innen

AARC scoreACLFAKIBiomarkerCholemic nephropathyDialysisHRSNGALRRT

Substanzen

TerlipressinLipocalin-2BiomarkersVasoconstrictor AgentsLCN2 protein, human

Autor:innen und Institutionen

  • Department of Hepatology, Institute of Liver and Biliary Sciences, D1 Vasant Kunj, New Delhi, 110070, India. rakhi_2011@yahoo.co.in.
  • Department of Statistics, Mizoram University (A Central University), Pachhunga University College Campus, Aizawl, India.
  • Department of Pathology, Institute of Liver and Biliary Sciences, New Delhi, India.
  • Department of Hepatology, Institute of Liver and Biliary Sciences, D1 Vasant Kunj, New Delhi, 110070, India.
  • Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, India.
  • Department of Biochemistry, Institute of Liver and Biliary Sciences, New Delhi, India.

Förderung

  • DST-SERB
  • ICMR

Zitieren

APA

Maiwall, R., Pasupuleti, S. S. R., Rastogi, A., Sharma, F., Hidam, A. K., Thomas, S., & Sarin, S. K. (2025). AARC score and urine NGAL predict terlipressin non-response and mortality in patients with acute-on-chronic liver failure. Hepatology International. https://doi.org/10.1007/s12072-024-10749-4

Vancouver

Maiwall R, Pasupuleti SSR, Rastogi A, Sharma F, Hidam AK, Thomas S, et al. AARC score and urine NGAL predict terlipressin non-response and mortality in patients with acute-on-chronic liver failure. Hepatology International. 2025. doi:10.1007/s12072-024-10749-4

BibTeX
@article{Maiwall2025,
  author = {Maiwall, Rakhi and Pasupuleti, Samba Siva Rao and Rastogi, Archana and Sharma, Fagun and Hidam, Ashini Kumar and Thomas, Sherin and Sarin, Shiv Kumar},
  title = {AARC score and urine NGAL predict terlipressin non-response and mortality in patients with acute-on-chronic liver failure},
  journal = {Hepatology International},
  year = {2025},
  doi = {10.1007/s12072-024-10749-4}
}
Kostenlos starten →